Senna Laxative by Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) / P & L Development, LLC DRUG FACTS

Senna Laxative by

Drug Labeling and Warnings

Senna Laxative by is a Otc medication manufactured, distributed, or labeled by Dolgencorp, Inc. (DOLLAR GENERAL & REXALL), P & L Development, LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SENNA LAXATIVE NATURAL VEGETABLE LAXATIVE- sennosides tablet 
Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

DRUG FACTS

Active Ingredient (in each tablet)

Sennosides 8.6 mg

Purpose

Laxative

Uses

  • relieves occasional constipation (irregularity)
  • generally produces a bowel movement in 6- 12 hours.

Warnings
Do not use

  • laxative products for longer than 1 week unless directed by a doctor.

Ask a doctor before use if you have

  • stomach pain
  • nausea
  • vomiting
  • noticed a sudden change in bowel movements that continues over a period of 2 weeks.

Stop use and ask a doctor if

  • you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

  • take preferably at bedtime or as directed by a doctor

 age

 starting dosage maximum dosage
 adults and children over 12 years of age or older 2 tablets once a day 4 tablets twice a day
 children 6 to under 12 years 1 tablet once a day 2 tablets twice a day
 children 2 to under 6 years  1/2 tablet once a day 1 tablet twice a day
 children under 2 years ask a doctor ask a doctor


Other information


  • each tablet contains: calcium 25 mg
  • store at 25o C (77o F); excursions permitted between 15o - 30o C (59o- 86o F)

Inactive Ingredients

croscarmellose sodium, dibasic calcium phosphate dihydrate, hypromellose, liquid paraffin*, magnesium stearate, maltodextrin*, microcrystalline cellulose, mineral oil*, silicon dioxide*, stearic acid*, sodium lauryl sulfate*, talc*, triacetin*

*contains one or more of these ingredients

Questions or comments?

Call toll free: 1-888-309-9030

Principal Display Panel

Compare to active ingredient in senokot® **

Senna Laxative

Sennosides 8.6 mg

Standardized senna concentrate

Natural vegetable laxative ingredient

**This product is not manufactured or distributed by Purdue Pharma L.P., owner of the registered trademark Senokot®

KEEP OUTER CARTON FOR COMPLETE WARNINGS AND PRODUCT INFORMATION

DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING

Product Label

Dollar General

Sennosides 8.6 mg

SENNA LAXATIVE  NATURAL VEGETABLE LAXATIVE
sennosides tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 55910-181
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE (UNII: O7TSZ97GEP)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
TALC (UNII: 7SEV7J4R1U)  
TRIACETIN (UNII: XHX3C3X673)  
MINERAL OIL (UNII: T5L8T28FGP)  
SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
Product Characteristics
ColorBROWNScoreno score
ShapeROUNDSize9mm
FlavorImprint Code S3;TCL080;S8
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 55910-181-011 in 1 BOX07/07/201001/01/2020
1100 in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH NOT FINALpart33407/07/201001/01/2020
Labeler - Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) (068331990)
Registrant - P & L Development, LLC (800014821)

Revised: 12/2012
 
Dolgenc

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.